B. Metzler seel. Sohn & Co’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,889	Closed	-$265K	–	727
2025 Q3	$265K	Hold	4,889	–	–	﹤0.01%	710
2025 Q2	$269K	Hold	4,889	–	–	﹤0.01%	706
2025 Q1	$346K	Hold	4,889	–	–	﹤0.01%	674
2024 Q4	$321K	Hold	4,889	–	–	﹤0.01%	698
2024 Q3	$344K	Sell	4,889 -2,546	-34%	-$213K	﹤0.01%	695
2024 Q2	$612K	Buy	7,435 +219	+3%	+$18.2K	0.01%	612
2024 Q1	$630K	Sell	7,216 -2,300	-24%	-$206K	0.01%	588
2023 Q4	$918K	Hold	9,516	–	–	0.01%	517
2023 Q3	$842K	Buy	9,516 +1,430	+18%	+$127K	0.01%	500
2023 Q2	$701K	Sell	8,086 -58,400	-88%	-$5.5M	0.01%	538
2023 Q1	$6.47M	Hold	66,486	–	–	0.1%	131
2022 Q4	$6.88M	Sell	66,486 -1,977	-3%	-$186K	0.12%	120
2022 Q3	$5.8M	Buy	68,463 +58,464	+585%	+$5.21M	0.11%	137
2022 Q2	$828K	Buy	9,999 +4,300	+75%	+$342K	0.01%	481
2022 Q1	$439K	Buy	5,699 +362	+7%	+$30.3K	0.01%	624
2021 Q4	$475K	Sell	5,337 -6,225	-54%	-$514K	0.01%	565
2021 Q3	$894K	Buy	11,562 +2,581	+29%	+$204K	0.01%	460
2021 Q2	$749K	Buy	8,981 +694	+8%	+$55K	0.01%	487
2021 Q1	$626K	Sell	8,287 -17,100	-67%	-$1.4M	0.01%	510
2020 Q4	$2.21M	Buy	+25,387	New	+$2.01M	0.04%	252